UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 3.820

Sortiert nach

Interventions for preventing oral candidiasis for patients with cancer receiving treatment

Cochrane database of systematic reviews, 2007-01 (1), p.CD003807

2007

Link zum Volltext

Verfügbarkeit prüfen

Predictive Performance of Physiologically Based Pharmacokinetic (PBPK) Modeling of Drugs Extensively Metabolized by Major Cytochrome P450s in Children

Clinical pharmacology and therapeutics, 2018-07, Vol.104 (1), p.188-200

2018

Link zum Volltext

Verfügbarkeit prüfen

Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent

Clinical infectious diseases, 2015-11, Vol.61 (10), p.1558-1565

2015

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and Pharmacodynamics of Posaconazole

Drugs (New York, N.Y.), 2020-05, Vol.80 (7), p.671-695

2020

Link zum Volltext

Verfügbarkeit prüfen

Tissue Penetration of Antifungal Agents

Clinical Microbiology Reviews, 2014-01, Vol.27 (1), p.68-88

2014

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection

Antimicrobial agents and chemotherapy, 2017-08, Vol.61 (8)

2017

Link zum Volltext

Verfügbarkeit prüfen

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy

Clinical pharmacology and therapeutics, 2017-07, Vol.102 (1), p.45-51

2017

Link zum Volltext

Verfügbarkeit prüfen

Population Pharmacokinetics of Isavuconazole from Phase 1 and Phase 3 (SECURE) Trials in Adults and Target Attainment in Patients with Invasive Infections Due to Aspergillus and Other Filamentous Fungi

Antimicrobial agents and chemotherapy, 2016-09, Vol.60 (9), p.5483-5491

2016

Link zum Volltext

Verfügbarkeit prüfen

Very Short and Stable Lactoferricin-Derived Antimicrobial Peptides: Design Principles and Potential Uses

Accounts of chemical research, 2019-03, Vol.52 (3), p.749-759

2019

Link zum Volltext

Verfügbarkeit prüfen

Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy

Journal of antimicrobial chemotherapy, 2019-08, Vol.74 (8), p.2341-2346

2019

Link zum Volltext

Verfügbarkeit prüfen

Echinocandin Resistance in Candida

Clinical infectious diseases, 2015-12, Vol.61 (suppl_6), p.S612-S617

Perlin, David S.

2015

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations

Journal of antimicrobial chemotherapy, 2017-03, Vol.72 (suppl_1), p.i12-i18

2017

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and Dosing of Anti-infective Drugs in Patients on Extracorporeal Membrane Oxygenation: A Review of the Current Literature

Clinical therapeutics, 2016-09, Vol.38 (9), p.1976-1994

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents

Clinical infectious diseases, 2009-05, Vol.48 (10), p.1441-1458

2009

Link zum Volltext

Verfügbarkeit prüfen

Antifungal resistance in dermatophytes: Recent trends and therapeutic implications

Fungal genetics and biology, 2019-11, Vol.132, p.103255-103255, Article 103255

2019

Link zum Volltext

Verfügbarkeit prüfen

Ibrexafungerp: A novel oral glucan synthase inhibitor

Medical mycology (Oxford), 2020-07, Vol.58 (5), p.579-592

2020

Link zum Volltext

Verfügbarkeit prüfen

Challenging Recommended Oral and Intravenous Voriconazole Doses for Improved Efficacy and Safety: Population Pharmacokinetics—Based Analysis of Adult Patients With Invasive Fungal Infections

Clinical infectious diseases, 2012-08, Vol.55 (3), p.381-390

2012

Link zum Volltext

Verfügbarkeit prüfen

Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi

Antimicrobial agents and chemotherapy, 2017-12, Vol.61 (12)

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase 1b study of new posaconazole tablet for prevention of invasive fungal infections in high-risk patients with neutropenia

Antimicrobial agents and chemotherapy, 2014-10, Vol.58 (10), p.5758-5765

2014

Link zum Volltext

Verfügbarkeit prüfen

Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis

Antimicrobial agents and chemotherapy, 2020-02, Vol.64 (3)

2020

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and Absorption of Posaconazole Oral Suspension under Various Gastric Conditions in Healthy Volunteers

Antimicrobial Agents and Chemotherapy, 2009-03, Vol.53 (3), p.958-966

2009

Link zum Volltext

Verfügbarkeit prüfen

Corneal targeted Sertaconazole nitrate loaded cubosomes: Preparation, statistical optimization, in vitro characterization, ex vivo permeation and in vivo studies

International journal of pharmaceutics, 2018-12, Vol.553 (1-2), p.386-397

2018

Link zum Volltext

Verfügbarkeit prüfen

Voriconazole metabolism is influenced by severe inflammation: a prospective study

Journal of antimicrobial chemotherapy, 2017-01, Vol.72 (1), p.261-267

2017

Link zum Volltext

Verfügbarkeit prüfen

SCY-078, a Novel Fungicidal Agent, Demonstrates Distribution to Tissues Associated with Fungal Infections during Mass Balance Studies with Intravenous and Oral [ 14 C]SCY-078 in Albino and Pigmented Rats

Antimicrobial agents and chemotherapy, 2019-02, Vol.63 (2)

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 3.820

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.620)
Mit Volltextzugriff
(3.075)

Publikationsform

Sprache

10 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(3.386)
Life Sciences & Biomedicine
(3.335)
Humans
(2.609)
Antifungal Agents - Pharmacokinetics
(2.464)
Pharmacology & Pharmacy
(2.240)
Male
(1.593)
Antifungal Agents
(1.585)
Biological And Medical Sciences
(1.581)
Medical Sciences
(1.535)
Pharmacology. Drug Treatments
(1.456)
Antifungal Agents - Administration & Dosage
(1.298)
Female
(1.257)
Animals
(1.251)
Pharmacokinetics
(1.068)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(1.057)
Antifungal Agents - Therapeutic Use
(1.007)
Adult
(1.002)
Microbiology
(963)
Antifungal Agents - Pharmacology
(918)
Pharmacology
(758)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Interventions for preventing oral candidiasis for patients with cancer receiving treatment

Predictive Performance of Physiologically Based Pharmacokinetic (PBPK) Modeling of Drugs Extensively Metabolized by Major Cytochrome P450s in Children

Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent

Pharmacokinetics and Pharmacodynamics of Posaconazole

Tissue Penetration of Antifungal Agents

Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy

Population Pharmacokinetics of Isavuconazole from Phase 1 and Phase 3 (SECURE) Trials in Adults and Target Attainment in Patients with Invasive Infections Due to Aspergillus and Other Filamentous Fungi

Bio-inspired crosslinking and matrix-drug interactions for advanced wound dressings with long-term antimicrobial activity

Very Short and Stable Lactoferricin-Derived Antimicrobial Peptides: Design Principles and Potential Uses

Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy

Echinocandin Resistance in Candida

Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations

Pharmacokinetics and Dosing of Anti-infective Drugs in Patients on Extracorporeal Membrane Oxygenation: A Review of the Current Literature

Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents

Antifungal resistance in dermatophytes: Recent trends and therapeutic implications

Ibrexafungerp: A novel oral glucan synthase inhibitor

Challenging Recommended Oral and Intravenous Voriconazole Doses for Improved Efficacy and Safety: Population Pharmacokinetics—Based Analysis of Adult Patients With Invasive Fungal Infections

Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi

Phase 1b study of new posaconazole tablet for prevention of invasive fungal infections in high-risk patients with neutropenia

Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis

Pharmacokinetics and Absorption of Posaconazole Oral Suspension under Various Gastric Conditions in Healthy Volunteers

Corneal targeted Sertaconazole nitrate loaded cubosomes: Preparation, statistical optimization, in vitro characterization, ex vivo permeation and in vivo studies

Voriconazole metabolism is influenced by severe inflammation: a prospective study

SCY-078, a Novel Fungicidal Agent, Demonstrates Distribution to Tissues Associated with Fungal Infections during Mass Balance Studies with Intravenous and Oral [ 14 C]SCY-078 in Albino and Pigmented Rats

Suchergebnisse filtern